市場調査レポート
商品コード
1451412
医療用解凍システム市場レポート:製品タイプ、サンプルタイプ、エンドユーザー、地域別、2024~2032年Medical Thawing System Market Report by Product Type (Manual, Automated), Sample Type (Blood, Embryo, Ovum, Semen), End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical and Biotech Companies, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
医療用解凍システム市場レポート:製品タイプ、サンプルタイプ、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
世界の医療用解凍システム市場規模は、2023年に2億550万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに3億7,280万米ドルに達し、2024年から2032年の間に6.63%の成長率(CAGR)を示すと予測しています。慢性疾患の有病率の増加、再生医療や個別化医療に対する需要の高まり、継続的な技術進歩が市場を牽引する主要要因の一つです。
医療用解凍システムは、血液製剤、ワクチン、組織サンプルなどの凍結生物学的標本を安全かつ迅速に解凍するために医療施設で使用されます。水浴中で凍結検体を加熱・攪拌する制御されたプロセスを採用しており、検体にダメージを与えることなく均一に解凍することができます。さらに、コンタミネーションのリスクを最小限に抑え、正確で信頼性の高い検査結果を保証し、凍結検体を扱う医療従事者の怪我のリスクを軽減します。医療用解凍システムは、生物学的マテリアルの取り扱いに関する厳しい規制基準を満たし、解凍された検体の品質と有効性を保証するために不可欠です。その結果、患者の治療や研究に使用される生物学的サンプルの品質と有効性を確保するための、信頼性が高く効率的で標準化された装置として、様々な医療施設で広く採用されています。
慢性疾患やウイルス・細菌感染症に罹患する患者数の増加は、市場成長を促進する主要要因の一つです。これに伴い、臓器移植への傾倒が高まり、臓器提供者の増加と輸血需要の急増が相まって、市場は良好な展望となっています。これに加えて、再生医療に対する需要の拡大が、幹細胞、組織、その他の生物学的サンプルの安全かつ効率的な解凍の必要性を煽っており、これが市場の成長に寄与しています。さらに、解凍システムの効率と精度を高めるための自動化やロボット技術の統合といった革新的な技術進歩が、市場に有益な成長機会をもたらしています。さらに、COVID-19ウイルスの発生は、感染の生物学的影響を調査し、新たな治療介入や予防戦略を特定するための組織標本の収集を促し、市場成長にプラスの影響を与えています。その他、高齢者人口の増加、医療支出の増加、献血キャンペーンへの参加者数の増加、個別化医薬品の需要の高まり、希少疾患の治療に有効な治療法を開発するための研究開発プロジェクトへの大規模な投資などが、市場の成長を強化しています。
The global medical thawing system market size reached US$ 205.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 372.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.63% during 2024-2032. The increasing prevalence of chronic diseases, the rising demand for regenerative and personalized medicines, and ongoing technological advancements represent some of the key factors driving the market.
A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.
The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, sample type and end user.
Manual
Automated
The report has provided a detailed breakup and analysis of the medical thawing system market based on the product type. This includes manual and automated. According to the report, the manual represented the largest segment.
Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen
A detailed breakup and analysis of the medical thawing system market based on the sample type has also been provided in the report. This includes blood (plasma, stem cells, whole blood and platelets), embryo, ovum and semen. According to the report, blood accounted for the largest market share.
Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others
The report has provided a detailed breakup and analysis of the medical thawing system market based on the end-user. This includes blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. According to the report, blood banks represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for medical thawing system. Some of the factors driving the North America medical thawing system market included the growing prevalence of life-threatening chronic diseases, the increasing adoption of regenerative and personalized medicines, and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.